Next Article in Journal
Unilateral Multifocal Follicular Thyroid Carcinoma with Vascular Invasion and Primary Hepatic Metastasis in a Dog: First Documented Case
Previous Article in Journal
Sustainable Use of Agro-Industrial By-Products as Feed in Finishing Pigs
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Veterinary Sciences
Volume 13
Issue 1
10.3390/vetsci13010042
vetsci-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Transmissible Gastroenteritis Virus Binding to Red Blood Cells Disrupts Iron Homeostasis and Promotes Viral Infection

by
Lu Xia
1,2,*,†,
Ziqi Wang
1,2,†,
Yeqing He
1,2,
Jingwen Wang
1,2,
Junyuan Ren
1,
Erhao Zhang
1,2,
Zhonghu Liu
1,
Yilei Li
1,2,
Zi Li
3 and
Zhanyong Wei
1,2,*
1
College of Veterinary Medicine, Henan Agricultural University, Zhengzhou 450046, China
2
Ministry of Education Key Laboratory for Animal Pathogens and Biosafety, Zhengzhou 450046, China
3
College of Veterinary Medicine, Jilin University, Changchun 130062, China
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Vet. Sci. 2026, 13(1), 42; https://doi.org/10.3390/vetsci13010042
Submission received: 1 November 2025 / Revised: 26 December 2025 / Accepted: 28 December 2025 / Published: 3 January 2026
Browse Figures
Review Reports Versions Notes

Simple Summary

Transmissible gastroenteritis virus (TGEV) is an enteric coronavirus, and numerous studies have focused on the interaction between TGEV and the intestinal tract. In our experiment, breathlessness was observed in TGEV-infected piglets, suggesting impaired oxygen uptake by RBCs. The effects of TGEV infection on red blood cells (RBCs) and its pathophysiological implications were explored. TGEV was found to bind to, but not replicate in, RBCs. TGEV binding to RBCs causes membrane structure damage, impairs oxygen-carrying capacity, promotes macrophage-mediated phagocytosis of damaged RBCs, and reduces serum iron levels, thereby facilitating viral infection. These findings highlight the importance of diagnostic technologies targeting RBCs and suggest new avenues for drug development and vaccine design for TGEV prevention. Further exploration of the mechanisms by which RBCs contribute to viral infection is warranted.

Abstract

Red blood cells (RBCs) are essential for transporting oxygen from lungs to peripheral tissues. However, the impact of transmissible gastroenteritis virus (TGEV) infection on RBCs and its potential pathophysiological significance during disease progression remain largely unexplored. In this study, hematological analysis of TGEV-infected piglets revealed significant reduction in both RBC distribution width–coefficient of variation and RBC distribution width–standard deviation, alongside elevated pCO2 levels. Viral detection confirmed the presence of TGEV within RBCs from infected piglets. Further investigation demonstrated that TGEV could bind to, but not replicate in, RBCs. TGEV-bound RBCs exhibited crenated and impaired deformability, which were associated with reduced oxygen-carrying capacity. Additionally, TGEV infection promoted macrophage-mediated phagocytosis of RBCs and led to decreased serum iron levels, factors that might enhance TGEV infection. Collectively, these results demonstrated the involvement of RBCs in the progression of TGEV infection, providing new insights for the development of diagnostic and therapeutic strategies.

1. Introduction

Transmissible gastroenteritis virus (TGEV) is a major enteric coronavirus responsible for vomiting, diarrhea, and dehydration. The virus was first discovered in the United States in 1946 and subsequently spread to Europe, Asia, Africa, and South America. All age groups of pigs are susceptible to TGEV infection, whereas morbidity and mortality in piglets younger than 2 weeks old can approach nearly 100% [1]. Surviving pigs usually show a relatively low growth rate or even become “stiff pigs”, resulting in significant economic losses to the swine industry. Although epidemiological surveys reported a decline in the prevalence of TGEV in recent years, the emergence of variant strains and coinfections with other enteric viruses has exacerbated disease severity [2,3,4]. Numerous studies have focused on the interaction between TGEV and the intestinal tract. The blood system plays critical roles in disease pathophysiology and mortality; however, its involvement in enterovirus infections remains unclear. In our clinical observations, piglets infected with TGEV exhibited not only diarrhea but also dyspnea, indicating impaired oxygen delivery to the lungs. These findings led us to hypothesize that TGEV disrupts the structure and function of red blood cells (RBCs).
RBCs are the most abundant cells in the blood and play a critical role in oxygen transport. Due to their lack of nucleus or organelles, mature mammal RBCs have long been considered incapable of supporting viral replication. However, accumulating evidence indicates that RBCs can interact with various viruses and contribute to viral pathogenesis. RBCs have been shown to bind human immunodeficiency virus (HIV-1), influenza A virus (IAV), adenovirus, Zika virus, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), suggesting that RBCs may serve as reservoirs [5,6,7]. Data showed that viral infection damages RBCs, leading to their recognition and clearance by macrophages. During erythrophagocytosis, iron is released and recycled for erythropoiesis. However, the underlying mechanisms driving these physiological and pathological changes during viral infection remain largely unexplored.
In the present study, we investigated the effects of TGEV infection on RBCs and its pathophysiological implications. Our results demonstrated that TGEV interacts with RBCs in a manner similar to other pathogens. Infection with TGEV resulted in significant alterations to hematological parameters in piglets. Further analyses revealed that TGEV binds to RBCs, causing membrane structure damage, impairing oxygen-carrying capacity, promoting macrophage-mediated phagocytosis of damaged RBCs, and reducing serum iron levels, thereby facilitating viral infection. These findings enhance our understanding of the progression of TGEV infection and provide novel insights into strategies for its prevention and vaccine design.

2. Materials and Methods

2.1. Cells and Viruses

Swine testicle (ST) cells and immortalized porcine alveolar macrophages (3D4/21) were purchased from the China Institute of Veterinary Drug Control. Cells were supplied in Dulbecco’s modified Eagle’s medium (DMEM; Gibco, Waltham, MA, USA) supplemented with 10% fetal bovine serum (FBS, Gibco) at 37 °C in a 5% CO2 humidified atmosphere. RBCs were isolated from whole blood collected from healthy pigs. Blood samples were mixed with lymphocyte separation medium (Solarbio, Beijing, China) and subjected to density gradient centrifugation at 1000× g for 30 min at room temperature using a horizontal centrifuge. RBCs were pelleted at the bottom of the tube, washed with D-Hanks’ solution (without Ca2+ and Mg2+), and stored in Alsever’s solution (Solarbio) at 4 °C.
The TGEV strain HN-2012 (Genbank: OP434397.1) was isolated by our laboratory. For virus infection assays, 107 RBCs were incubated with TGEV at a multiplicity of infection (MOI) of 1. For the adhesion assay, RBCs were incubated with TGEV at 4 °C for 1 h. For the invasion assay, cells were incubated with TGEV at 37 °C for 1 h. For the time-course assays, cells were incubated with TGEV at 37 °C for 3, 6, 12, 24, 36, and 48 h. At each indicated time point, cells were washed with PBS to remove unbound virus and collected for analysis. Monolayer ST cells were also incubated with TGEV at 37 °C 1 h. Maintenance medium was then added for subsequent analyses.

2.2. Animals Challenge

Six 3-day-old healthy male piglets (Duroc × Landrace × Yorkshire) were obtained from a herd that had been confirmed to be free of TGEV, porcine epidemic diarrhea virus (PEDV), porcine deltacoronavirus (PDCoV), and porcine rotavirus (PoRV) by polymerase chain reaction (PCR) prior to purchase. All piglets were housed and cared for in accordance with the guidelines of the National Standard for Laboratory Animals and were allowed a two-day acclimation period to initiate the experiment. Piglets were randomly assigned to two groups: a control group (control) and a TGEV-infected group (TGEV). Animals were orally inoculated with 10 mL of DMEM (control) or TGEV (107 TCID50) and housed in a separate room. Blood samples were collected using heparin as an anticoagulant at 72 h post-infection (hpi). Subsequently, all piglets were euthanized by intravenous injection of sodium pentobarbital (100 mg/kg body weight). Lung and small intestine samples were obtained and stored in liquid nitrogen or 4% paraformaldehyde.

2.3. Blood Collection and Analysis

Peripheral blood (2 mL) was collected from healthy or TGEV infected piglets into hemogram tubes with ethylenediaminetetraacetic acid (EDTA). Hematological parameters and plasma iron concentrations were measured with a BS-330E Automated Hematology Analyzer (Mindray, Shenzhen, China). Blood pH value and gas parameters were analyzed with an Abbott i-STAT System (Chicago, IL, USA).

2.4. RNA Extraction and Reverse Transcription Quantitative PCR (RT-qPCR) Assay

Total RNA was extracted from RBCs using FreeZol reagent (Vazyme, Nanjing, China). A total of 500 ng RNA was reverse transcription into cDNA using a HiScript II Reverse Transcriptase reagent kit (Vazyme) according to the manufacturer’s instructions. RT-qPCR was performed with a ChamQ Universal SYBR qPCR Master Mix kit (Vazyme). Specific primers targeting TGEV N gene were F: 5′-TGAAGGGCCAACGTAAAGAG-3′, R: 5′-CAACCCAGACAACTCC ATCTAA-3′.

2.5. Plaque Assay

The titer of TGEV in RBCs was determined by a plaque assay. TGEV was released from 107 RBCs by freeze–thaw cycles in 400 μL DMEM. ST cells were seeded into 6-well plates, and 10-fold serial dilutions of TGEV (100 μL) were adsorbed onto monolayers at 37 °C for 1 h. Then cells were washed with PBS and overlaid with medium (containing DMEM, 2% FBS, and 1% low-melting-point agarose) for 72 h. Subsequently, cells were fixed and stained with 1% crystal violet solution prepared in methanol. Plaques were counted, and viral titers were expressed as plaque-forming units per mL (PFU/mL).

2.6. Flow Cytometry Analysis

The proportion of TGEV-positive RBCs was determined by flow cytometry. TGEV-infected RBCs were collected at the different time points post-infection. Cells were washed three times with PBS to remove unbound virus and then incubated with rabbit anti-TGEV polyclonal antibody (1:50, prepared by our laboratory) at 37 °C for 2 h. After washing three times with PBS, cells were stained with FITC-conjugated Goat anti-Rabbit IgG (1:100, Proteintech, Wuhan, China) for 30 min, washed again, and resuspended in 100 μL PBS. The percentage of TGEV-positive RBCs were analyzed using 105 cells on a BD FACSCanto (Franklin Lakes, NJ, USA). Data were processed with FlowJo 10 software.

2.7. Prussian Blue Staining

Spleen tissues from piglets were collected and fixed for histological sectioning. After dewaxing and rehydration with xylene and gradient alcohol, the sections were incubated in Prussian blue solution for 30 min, rinsed with running water, and counterstained with eosin for 3 min. After dehydration and clearing, sections were mounted with gum for microscopic examination.

2.8. Diff-Quik Staining

To observe the morphology of RBCs, cells were suspended in PBS and smeared onto glass slide. After air drying, the smears were stained with a Diff-Quik staining kit (Solarbio) according to the manufacturer’s instructions.

2.9. Scanning Electron Microscope (SEM)

RBCs were fixed with 2.5% glutaraldehyde at 4 °C overnight. Samples were dehydrated through a graded ethanol serious, resuspended in anhydrous ethanol, mounted on tinfoil, and sputter-coated with gold. Images were acquired using an SEM (FEI).

2.10. Osmotic Fragility Test

Osmotic fragility was used to evaluate the integrity of the RBC membranes and detected by an Erythrocyte Osmotic Brittleness Test Kit (Solarbio). RBCs were incubated in NaCl solution of varying concentrations for 30 min. Membrane disruption led to hemolysis and release of hemoglobin, which was quantified by a measuring absorbance at 540 nm using a microplate reader (Thermos Scientific, Waltham, MA, USA). The hemoglobin concentration reflected the percentage of RBC lysis.

2.11. Phosphatidylserine (PS) Measurement

Externalization of PS on the RBC membranes was assessed by an Annexin V-FITC kit (Beyotime, Beijing, China). RBCs were resuspended in Annexin V-FITC binding buffer at a density of 1 × 106 cells/mL. Annexin V-FITC (5 μL) was added to the suspension and incubated for 20 min at room temperature. Cells were then washed with PBS and analyzed by flow cytometry (BD).

2.12. Raman Spectroscopy Analysis

Hemoglobin content in RBCs was quantified using Raman spectroscopy (HORIBA Paris, France). Single RBCs suspended in PBS were irradiated with a 532 nm laser at a maximum power of 100 mW. A 100× objective lens was used to collect spectra within the range of 300–2000 cm−1. Each sample was scanned with an exposure time of 15 s, repeated for two cycles. For each experimental group, spectra were collected from at least 10 individual cells. Peak assignments of the Raman spectra are summarized in Table 1.

2.13. Detection of Oxyhemoglobin and Methemoglobin

The levels of oxyhemoglobin and methemoglobin in RBCs (1 × 107 cells) were detected by a Methemoglobin content assay kit (Solarbio). Briefly, RBCs were washed with PBS and detected at the absorbance of 560 nm and 630 nm by a spectrophotometer.

2.14. Western Blot (WB) Analysis

Total proteins were extracted, mixed with loading buffer, and boiled. Cellular proteins were separated by 12% sodium dodecyl sulfate–polyacrylamide gel electrophoresis and transferred to PVDF membranes. The membranes were blocked with 5% non-fat milk for 2 h and then incubated with monoclonal antibody against TGEV N protein (1:3000, prepared by our laboratory) or Anti-Transferrin Receptor antibody (1:1000, Abcam, Cambridge, UK) at 4 °C overnight. After three washes with TBST, membranes were incubated with HRP-conjugated Goat Anti-Mouse IgG or HRP-conjugated Goat Anti-Rabbit IgG (1:5000, Proteintech) for 2 h. Proteins were visualized using an enhanced chemiluminescence reagent (Beyotime) and imaged using an AmershamImager800 system.

2.15. Statistical Analysis

Data are expressed as the means ± standard deviations (SDs) from three independent experiments. All data in this study were analyzed using one-way ANOVA by SPSS version 26.0 software. Different letters indicate significant difference (p < 0.05), whereas identical letters indicate no significant difference (p > 0.05).

3. Results

3.1. Comparison of Hematological Parameters Between Healthy and TGEV-Infected Piglets

To confirm TGEV had established a successful infection, 5-day-old piglets were challenged with TGEV. Lung and small intestine samples were collected, and total RNA was extracted and subjected to RT-qPCR. As shown in Figure 1, the limit of detection for TGEV was approximately 103.8 copies/mL. Viral loads in the lungs were significantly higher than those in the small intestine.
Since TGEV-infected piglets exhibited symptoms of hypoxia, the effects of TGEV infection on RBCs were firstly evaluated by hematology parameters. Blood specimens from TGEV-infected and healthy piglets were compared (Table 2). Both RBC distribution width–coefficient of variation (RDW_CV) and RBC distribution width–standard deviation (RDW_SD) were significantly lower in TGEV-infected piglets than healthy controls. Other parameters, including RBC count, hemoglobin (HGB), hematocrit (HCT), mean corpuscular volume (MCV), platelet count (PLT), mean platelet volume (MPV), platelet distribution width (PDW), and plateletcrit (PCT), were also lower in TGEV-infected piglets, although the difference were not statistically significant. Given that RBCs are responsible for transporting oxygen and carbon dioxide, blood pH and blood gas levels were further analyzed. The pCO2 was markedly elevated in TGEV-infected piglets, while blood pH and pO2 remained unaffected.

3.2. Detection of TGEV RNA in RBCs from Infected Piglets

To assess whether TGEV can infect RBCs, blood samples were collected from TGEV-infected piglets. High levels of TGEV RNA were detected in RBCs from one of the three piglets (Figure 2A). No plaque was observed in samples from any piglet, except for TGEV-positive samples, where plaque formation was evident (Figure 2B). Flow cytometry confirmed a low percentage of TGEV-infected RBCs (Figure 2C,D). Together, these results indicated that TGEV can infect RBCs.

3.3. TGEV Binds to RBCs

To investigate the infection characteristics of TGEV in RBCs, RBCs from healthy piglets were isolated, incubated with TGEV, and collected at different time points post-infection. RT-qPCR analysis showed that TGEV mRNA levels gradually decreased over time (Figure 3A). The plaque assay indicated that viral titers were undetectable at 12 hpi (Figure 3B,C). Flow cytometry further validated that the percentage of TGEV-positive cells continuously declined and was no longer detectable at 12 hpi (Figure 3D,E). Considering the first replication cycle of coronavirus is approximately 6 h, these findings suggested that TGEV can bind to, but not replicate in, RBCs [8,9].
Sialic acid (SA), a major glycocalyx carbohydrate on RBCs, has been reported to function as an adhesion receptor during TGEV infection. To assess the role of SA in TGEV binding, RBCs were pretreated with 0.1 U/mL neuraminidase (NA) prior to TGEV inoculation. RT-qPCR revealed that TGEV mRNA expression in NA-treated RBCs was significantly reduced at both the adhesion and invasion stages (Figure 4A). Consistent with the RT-qPCR results, virus titers (Figure 4B,C) and the proportion of TGEV-positive cells (Figure 4D,E) were also decreased after NA pretreatment. These results demonstrated that SA is an important mediator of TGEV binding to RBCs.

3.4. TGEV Binding Results in Structural Damage to RBCs

Because viral infection can cause damage to the RBCs, the effects of TGEV binding on RBC morphology, deformability, and osmotic fragility were examined. Diff-Quik staining revealed that normal RBCs were round and smooth, whereas TGEV-exposed RBCs appeared wrinkled, crenated, and displayed membrane extensions (Figure 5A). Flow cytometry analysis showed that an increase in side scatter (SSC), which reflects cellular complexity, suggesting membrane protrusions. In contrast, forward scatter (FSC), which reflects cell size, was decreased, likely due to cellular shrinkage (Figure 5B). SEM images further demonstrated that normal RBCs had a diameter of 5 to 7 μm, while TGEV-infected RBCs displayed numerous protrusions characteristic of “echinocytes” (Figure 5C).
Osmotic fragility, an important indicator of RBC membrane stability, was significantly increased with both prolonged infection and higher infection doses (Figure 6A,B), suggesting reduced deformability of TGEV-infected RBCs. Additionally, exposure of PS on the RBC surface was markedly elevated following TGEV infection and increased with time (Figure 6C,D). These findings collectively demonstrated that TGEV infection disrupts RBC membrane integrity.

3.5. TGEV Decreases the Oxygen-Carrying Capacity of RBCs

The structure integrity of RBCs is closely linked to their oxygen transport function. To assess the effect of TGEV infection on RBC function, oxygen contents in RBCs were analyzed using Raman spectroscopy. The average Raman spectra of control and TGEV-infected RBCs are shown in Figure 7A. The 1225 cm−1 band, corresponding to the bending vibration of the C-H methyl plane and known to weaken under hypoxic conditions, was reduced in TGEV-infected cells. The bands at 1355 cm−1 and 1375 cm−1 serve as reference indicators to distinguish hypoxia from oxygen-rich states. The peak at 1639 cm−1, which reflects high oxygen content, was also diminished in TGEV-infected RBCs. Moreover, the 1375 cm−1 peak shifted to 1355 cm−1 after infection. The ratio of Raman intensity at 1375 cm−1/1355 cm−1, representing the relative abundance of hemoglobin and ligand complexes (oxyhemoglobin), was significantly decreased (Figure 7B). Oxyhemoglobin levels were further measured by a methemoglobin assay. As shown in Figure 7C, oxyhemoglobin progressively declined with prolonged TGEV infection. In contrast, methemoglobin, which is incapable of oxygen transport, was increased (Figure 7D). These results demonstrated that TGEV infection reduces the oxyhemoglobin content and compromises the oxygen-carrying function of piglet RBCs.

3.6. TGEV Binding Enhances Macrophage Phagocytosis of RBCs

Aging or structurally damaged RBCs are normally cleared by macrophages. To determine whether TGEV infection influences erythrophagocytosis, macrophages were co-cultured with TGEV-pretreated RBCs. Macrophage SSC values increased after exposure to RBCs and further elevated when TGEV-infected RBCs were added (Figure 8A). When RBCs were labeled with a live-cell fluorescent dye and co-cultured with macrophages, the fluorescence intensity of macrophages engulfing TGEV-infected RBCs was stronger than that of macrophages exposed to uninfected RBCs (Figure 8B,C). These findings indicated that TGEV infection enhances macrophage phagocytosis of RBCs.

3.7. Iron Influence TGEV Infection

Normal iron homeostasis is disrupted during viral infections. Hemosiderin, an iron-storage complex formed after macrophages engulf RBCs, can be detected by Prussian blue staining. As shown in Figure 9A, abundant blue granules of hemosiderin were observed in the spleen and liver of TGEV-infected piglets, indicating iron was “locked” in macrophages, which may limit iron export and contribute to low plasma iron. Consistent with this observation, serum iron levels in TGEV-infected piglets were significantly decreased (Figure 9B). Transferrin receptor 1 (TFR1) has been demonstrated to serve as the invasion receptor for TGEV [10]. To further assess the effect of the iron concentration on viral infection, ST cells were pretreated with the iron chelator deferoxamine mesylate (DFOM) to limit iron availability or with ferric ammonium citrate (FAC) to supplement iron and then infected with TGEV. DFOM treatment enhanced the expression of TFR1, while FAC treatment inhibited its expression (Figure 9C). TGEV mRNA and protein expression were increased in DFOM-treated cells, whereas FAC decreased viral infection (Figure 9D,E). These results suggested that erythrophagocytosis-mediated alterations in iron levels can modulate TGEV infection.

4. Discussion

TGEV is a major swine coronavirus that causes fatal diarrhea in piglets less than two weeks old. The prevalence of TGEV has decreased over the decades due to vaccination. However, variant TGEV strains have been reported in US and China. Large amounts of virions are present in the small intestine and lungs [4]. The virulence, tropism, and pathogenicity of these recombinant TGEV strains have evolved, complicating the prevention and control of TGEV. During our experiment, breathlessness was observed in TGEV-infected piglets, which was suspected to be related to altered oxygen uptake by RBCs. Hypoxia, a hallmark of SARS-CoV-2 pneumonia, has prompted increased interest in the interactions between viruses and RBCs. Therefore, effects of TGEV infection on RBCs and potential pathophysiological roles in disease progression were explored in this study.
As obligate intracellular parasites, viruses rely on host cellular machinery for genome replication and protein synthesis. Because mature RBCs in mammals lack nuclei and other organelles, their involvement in viral infections is often overlooked. However, studies have shown that RBCs can act as temporary “transport vehicles”, facilitating the spread of viruses through the bloodstream [7]. Our results demonstrated that TGEV could bind to RBCs, suggesting TGEV has the ability to infect RBCs. Clinically, the presence of viral RNA in the blood is termed viremia. Detection of viral RNA in plasma samples has been observed in 75% of SARS-CoV-2 and 90% of PEDV infections, respectively [11,12]. Furthermore, PDCoV has been identified in blood samples from piglets and Haitian children [13,14,15]. Since coronavirus can be detected in multiple organs, viremia may contribute to the distant transmission of the virus, leading to broad tissue tropism [16,17]. Additionally, viremia is associated with disease severity and high mortality [18,19]. Collectively, these findings enhance our understanding of TGEV infection and transmission, highlighting the importance of diagnostic technologies targeting RBCs.
Viral infections are initiated by attachment to host cell receptors. In the case of RBCs, viruses bind primarily to the plasma membrane, transmembrane proteins, or glycocalyx carbohydrates [7]. Although specific viral receptors are not expressed on RBCs, SA has been shown to interact with the spike (S) protein of coronavirus. TGEV binds to SAs through the N-terminal domain (NTD) of its S protein [20,21]. SARS-CoV-2 attaches to SA primarily through glycans at 22 N-glycosylation sites on the viral S1 protein [22]. Pretreatment of RBCs with NA reduced partial TGEV adhesion, suggesting other components of the RBC membrane might contribute to TGEV infection. Band 3, CD147, and β1 chains of hemoglobin have been reported as potential binding receptors for SARS-CoV-2 infecting RBCs [23,24]. Given RBCs’ ability to express viral receptors and permeate all organs, they can be selectively coated with viral receptors to minimize the invasion of infectious particles into susceptible tissues or loaded with drugs to eliminate virus-infected cells [25,26]. These findings offer new insights into the prevention and control of TGEV, and the precise mechanism by which TGEV binds to RBCs warrants further investigation.
Abnormalities in RBCs are commonly observed in many infectious diseases. The frequency of diverse RBC morphology may serve as a predictor of disease severity during virus infection. In TGEV-infected RBCs, serrated, elongated, and crenated morphologies were observed likely due to defects in RBC membrane composition. Thomas et al. combined multi-omics approaches to investigate the impact of SARS-CoV-2 infection on RBC membrane composition. Proteomics analysis revealed that ankyrin, spectrin β, and band 3, which comprise the response maintaining RBC membrane integrity, underwent oxidation and fragmentation. Lipidomics data indicated viral infection significantly reduced the synthesis of lipid classes, altering membrane lipids remodeling pathways. Metabolomics showed an increase in glycolytic activity in SARS-CoV-2-infected RBCs, which may theoretically enhance hemoglobin’s oxygen off-loading to counteract hypoxia [27,28].
Dysfunctional RBCs result in a limited oxygen supply, contributing to hypoxia and associated complications. Hemoglobin, the primary oxygen carrier, is responsible for approximately 98% of total oxygen transport. TGEV infection reduced oxygen supply by binding to RBCs, potentially causing hemoglobin damage. Wiedemann et al. found that SARS-CoV-2 can directly infect RBC progenitors, impairing hemoglobin synthesis during RBC maturation and turnover [29]. Liu and Lechuga et al. further demonstrated that multiple SARS-CoV-2 proteins act as potential ligands binding to hemoglobin, inducing hemoglobin denaturation and dysfunction, which in turn impairs oxygen uptake, binding, or release [30]. In TGEV-infected piglets, altered hematological parameters were consistent with impaired oxygen delivery. However, due to limitations in the number of animals, hematological changes in TGEV-infected piglets should be further investigated. Numerous clinical studies have indicated that COVID-19 is associated with changes in hematological parameters, which are more pronounced in patients with severe diseases [31]. Notably, abnormal hematological parameters and morphological changes were observed even after 60 days’ recovery from mild COVID-19, suggesting that coronavirus may cause long-term effects in hosts [32]. Together, these results demonstrated that TGEV infection reduced oxygen supply of RBCs and may cause other symptoms such as anemia.
Currently, there are no reports describing TGEV-induced RBC damage or its underlying mechanisms. Based on the literature, we speculate that there are potential mechanisms by which TGEV affects RBCs. TGEV binds to RBCs via membrane-associated receptors, subsequently altering the cytoskeleton beneath the plasma membrane, leading to morphological abnormalities and disrupting hemoglobin, thereby impairing RBC function.
Old or diseased RBCs are typically engulfed by macrophages in the red spleen or liver. Two factors contribute to macrophage-mediated RBC clearance. First, TGEV infection reduces RBC deformability, preventing the cells from passing through inter-endothelial slits and capillaries narrower than the RBC diameter. Second, several pro-phagocytic signals are generated to recruit macrophages. PS, normally located on the inner leaflet of the healthy RBC membrane, can act as an “eat me” signal when exposed on the outer leaflet under some pathological conditions. Additionally, membrane protein CD47 interacts with signal-regulatory protein alpha to inhibit phagocytosis. Clustering and conformational changes in band 3 are recognized by natural antibodies, leading to the formation of immune complexes with complement C3, which triggers phagocytosis [7,33,34]. These phagocytic signals are essential for RBC clearance. Enhanced PS exposure in TGEV-infected RBCs was consistent with increased macrophage-mediated RBC engulfment. Although macrophages are immune cells that defense against viral invasion, erythrophagocytosis can capture viruses, providing an alternative route facilitating viral entry into the cells [35]. African swine fever virus (ASFV) has been shown to adsorb to RBCs, inducing apoptosis and enhancing macrophage phagocytosis, which in turn increases the efficiency of ASFV entry [36]. Currently, vaccines utilizing RBCs to deliver antigens to macrophages are being developed to induce specific cellular immunity.
Macrophages scavenge RBCs to release iron into the circulatory system. Iron is crucial for developing erythroblasts and is also an essential nutrient for microbial infection. In the host, absorbed iron is bound to transferrin, which interacts with its receptor, TFR1, on the cell surface for internalization. Recent studies have shown that iron chelator DFOM or iron supplements like FAC can alter iron balance and affect viral infection [37]. TFR1 has also been confirmed to act as a receptor mediating various virus invasion, including SARS-CoV-2, IAV, PEDV, and TGEV [10,38,39,40]. Clinically, newborn piglets are highly susceptible to PEDV infection, partly due to iron deficiency and the high expression levels of TFR1, which facilitate viral infection [40]. Our results showed that iron levels in TGEV-infected piglets were deposited in the spleen as hemosiderin, while plasma iron levels were reduced, potentially favoring viral infection through enhanced TFR1 expression in intestinal epithelial cells. Low serum iron had been reported to contribute to dengue virus, SARS-CoV-2, and HIV infection [29,41,42]. Serum iron levels in severe COVID-19 patients were significantly lower than those in mild COVID-19, suggesting a strong correlation between low serum iron and disease severity. Thus, providing an appropriate amount of iron may be crucial for defense against pathogen infections.

5. Conclusions

In summary, our study demonstrates that TGEV infection results in injury to RBCs and induces hypoxia in piglets, which plays a significant role in the disease progression of viral infection. Our findings underscore the potential of diagnostic technologies targeting RBCs and suggest new avenues for drug development and vaccine design for TGEV prevention. Further exploration of the mechanisms by which RBCs contribute to viral infection is warranted.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/vetsci13010042/s1, Figure S1: Original plaque assay for the role of SA in TGEV binding to RBCs; Figure S2: Original image depicting the effects of DFOM or FAC on TGEV infection.

Author Contributions

Conceptualization, L.X. and Z.L. (Zhonghu Liu); Methodology, Z.W. (Ziqi Wang), Y.H., J.W., J.R., E.Z. and Y.L.; Software, Z.W. (Ziqi Wang) and Y.H. Validation, Y.H. and J.W.; Formal Analysis, Z.W. (Ziqi Wang) and Y.H.; Data Curation, L.X.; Writing—Original Draft Preparation, L.X.; Writing—Review and Editing, L.X., Z.L. (Zi Li) and Z.W. (Zhanyong Wei); Visualization, Z.W. (Ziqi Wang), Y.H., J.W., J.R. and E.Z.; Supervision, L.X. and Z.W. (Zhanyong Wei); Project Administration, L.X. and Z.W. (Zhanyong Wei); Funding Acquisition, L.X. and Z.W. (Zhanyong Wei). All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the National Key Research and Development Program of China [grant No. 2022YFD1801400]; Program for Innovative Research Team (in Science and Technology) in University of Henan Province [grant No. 24IRTSTHN034]; and the National Natural Science Foundation of China (Key Program) [grant No. 32130106].

Institutional Review Board Statement

All animal experiments were conducted in accordance with the guidelines of laboratory animals of Henan Agricultural University (Zhengzhou, China). The animal study was reviewed and approved by the Animal Ethics Committee of Henan Agricultural University (Approval No. HNND-2024031116 approved on 8 March 2023).

Informed Consent Statement

Not applicable.

Data Availability Statement

The original contributions presented in this study are included in the article/Supplementary Materials. Further inquiries can be directed to the corresponding authors.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript. Hpi, hours post-infection; MOI, multiplicity of infection; RBC, red blood cell; TGEV, transmissible gastroenteritis virus; PFU, plaque-forming unit.

References

  1. Chen, Y.; Zhang, Y.; Wang, X.; Zhou, J.; Ma, L.; Li, J.; Yang, L.; Ouyang, H.; Yuan, H.; Pang, D. Transmissible Gastroenteritis Virus: An Update Review and Perspective. Viruses 2023, 15, 359. [Google Scholar] [CrossRef] [PubMed]
  2. Chen, F.; Knutson, T.P.; Rossow, S.; Saif, L.J.; Marthaler, D.G. Decline of transmissible gastroenteritis virus and its complex evolutionary relationship with porcine respiratory coronavirus in the United States. Sci. Rep. 2019, 9, 3953. [Google Scholar] [CrossRef]
  3. Zhang, F.; Luo, S.; Gu, J.; Li, Z.; Li, K.; Yuan, W.; Ye, Y.; Li, H.; Ding, Z.; Song, D.; et al. Prevalence and phylogenetic analysis of porcine diarrhea associated viruses in southern China from 2012 to 2018. BMC Vet. Res. 2019, 15, 470. [Google Scholar] [CrossRef] [PubMed]
  4. Xu, L.; Dai, H.B.; Luo, Z.P.; Zhu, L.; Zhao, J.; Lee, F.Q.; Liu, Z.Y.; Nie, M.C.; Wang, X.T.; Zhou, Y.C.; et al. Characterization and Evaluation of the Pathogenicity of a Natural Gene-Deleted Transmissible Gastroenteritis Virus in China. Transbound. Emerg. Dis. 2023, 2023, 2652850. [Google Scholar] [CrossRef]
  5. Lam, L.K.M.; Dobkin, J.; Eckart, K.A.; Gereg, I.; DiSalvo, A.; Nolder, A.; Anis, E.; Ellis, J.C.; Turner, G.; Mangalmurti, N.S. Bat Red Blood Cells Express Nucleic Acid-Sensing Receptors and Bind RNA and DNA. Immunohorizons 2022, 6, 299–306. [Google Scholar] [CrossRef]
  6. Lam, L.K.M.; Murphy, S.; Kokkinaki, D.; Venosa, A.; Sherrill-Mix, S.; Casu, C.; Rivella, S.; Weiner, A.; Park, J.; Shin, S.; et al. DNA binding to TLR9 expressed by red blood cells promotes innate immune activation and anemia. Sci. Transl. Med. 2021, 13, eabj1008. [Google Scholar] [CrossRef]
  7. Johansson, E.; Falk, A.B. Erythrocytes as Biomarkers of Virus and Bacteria in View of Metal Ion Homeostasis. In Erythrocyte—A Peripheral Biomarker for Infection and Inflammation; Fatima-Shad, K., Ed.; IntechOpen: Rijeka, Croatia, 2021. [Google Scholar]
  8. Ding, L.; Huang, Y.; Dai, M.; Zhao, X.; Du, Q.; Dong, F.; Wang, L.; Huo, R.; Zhang, W.; Xu, X.; et al. Transmissible gastroenteritis virus infection induces cell cycle arrest at S and G2/M phases via p53-dependent pathway. Virus Res. 2013, 178, 241–251. [Google Scholar] [CrossRef]
  9. Qin, P.; Du, E.Z.; Luo, W.T.; Yang, Y.L.; Zhang, Y.Q.; Wang, B.; Huang, Y.W. Characteristics of the Life Cycle of Porcine Deltacoronavirus (PDCoV) In Vitro: Replication Kinetics, Cellular Ultrastructure and Virion Morphology, and Evidence of Inducing Autophagy. Viruses 2019, 11, 455. [Google Scholar] [CrossRef]
  10. Zhang, S.; Hu, W.; Yuan, L.; Yang, Q. Transferrin receptor 1 is a supplementary receptor that assists transmissible gastroenteritis virus entry into porcine intestinal epithelium. Cell Commun. Signal 2018, 16, 69. [Google Scholar] [CrossRef]
  11. Jacobs, J.L.; Mellors, J.W. Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA in Blood of Patients with Coronavirus Disease 2019 (COVID-19): What Does It Mean? Clin. Infect. Dis. 2021, 73, e2898–e2900. [Google Scholar] [CrossRef] [PubMed]
  12. Madson, D.M.; Arruda, P.H.; Magstadt, D.R.; Burrough, E.R.; Hoang, H.; Sun, D.; Bower, L.P.; Bhandari, M.; Gauger, P.C.; Stevenson, G.W.; et al. Characterization of Porcine Epidemic Diarrhea Virus Isolate US/Iowa/18984/2013 Infection in 1-Day-Old Cesarean-Derived Colostrum-Deprived Piglets. Vet. Pathol. 2016, 53, 44–52. [Google Scholar] [CrossRef]
  13. Lednicky, J.A.; Tagliamonte, M.S.; White, S.K.; Elbadry, M.A.; Alam, M.M.; Stephenson, C.J.; Bonny, T.S.; Loeb, J.C.; Telisma, T.; Chavannes, S.; et al. Independent infections of porcine deltacoronavirus among Haitian children. Nature 2021, 600, 133–137. [Google Scholar] [CrossRef]
  14. Suzuki, T.; Shibahara, T.; Imai, N.; Yamamoto, T.; Ohashi, S. Genetic characterization and pathogenicity of Japanese porcine deltacoronavirus. Infect. Genet. Evol. 2018, 61, 176–182. [Google Scholar] [CrossRef]
  15. Jung, K.; Hu, H.; Saif, L.J. Porcine deltacoronavirus infection: Etiology, cell culture for virus isolation and propagation, molecular epidemiology and pathogenesis. Virus Res. 2016, 226, 50–59. [Google Scholar] [CrossRef]
  16. Li, J.; Yuan, C.; Liu, P.; Li, Y.; Zhang, P.; Yang, Q. Red blood cells serve as a vehicle for PEDV transmission. Vet. Microbiol. 2021, 257, 109081. [Google Scholar] [CrossRef] [PubMed]
  17. Hagman, K.; Postigo, T.; Diez-Castro, D.; Ursing, J.; Bermejo-Martin, J.F.; de la Fuente, A.; Tedim, A.P. Prevalence and clinical relevance of viraemia in viral respiratory tract infections: A systematic review. Lancet Microbe 2025, 6, 100967. [Google Scholar] [CrossRef] [PubMed]
  18. Hagman, K.; Hedenstierna, M.; Rudling, J.; Gille-Johnson, P.; Hammas, B.; Grabbe, M.; Jakobsson, J.; Dillner, J.; Ursing, J. Duration of SARS-CoV-2 viremia and its correlation to mortality and inflammatory parameters in patients hospitalized for COVID-19: A cohort study. Diagn. Microbiol. Infect. Dis. 2022, 102, 115595. [Google Scholar] [CrossRef]
  19. Jacobs, J.L.; Bain, W.; Naqvi, A.; Staines, B.; Castanha, P.M.S.; Yang, H.; Boltz, V.F.; Barratt-Boyes, S.; Marques, E.T.A.; Mitchell, S.L.; et al. Severe Acute Respiratory Syndrome Coronavirus 2 Viremia Is Associated with Coronavirus Disease 2019 Severity and Predicts Clinical Outcomes. Clin. Infect. Dis. 2021, 74, 1525–1533. [Google Scholar] [CrossRef]
  20. Olech, M.; Antas, M. Transmissible Gastroenteritis Virus (TGEV) and Porcine Respiratory Coronavirus (PRCV): Epidemiology and Molecular Characteristics—An Updated Overview. Viruses 2025, 17, 493. [Google Scholar] [CrossRef]
  21. Yuan, Y.; Zu, S.; Zhang, Y.; Zhao, F.; Jin, X.; Hu, H. Porcine Deltacoronavirus Utilizes Sialic Acid as an Attachment Receptor and Trypsin Can Influence the Binding Activity. Viruses 2021, 13, 2442. [Google Scholar] [CrossRef] [PubMed]
  22. Scheim, D.E. A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at Its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and Antibody. Int. J. Mol. Sci. 2022, 23, 2558. [Google Scholar] [CrossRef]
  23. Jung, F.; Connes, P. Morphology and Function of Red Blood Cells in COVID-19 Patients: Current Overview 2023. Life 2024, 14, 460. [Google Scholar] [CrossRef]
  24. Russo, A.; Tellone, E.; Barreca, D.; Ficarra, S.; Laganà, G. Implication of COVID-19 on Erythrocytes Functionality: Red Blood Cell Biochemical Implications and Morpho-Functional Aspects. Int. J. Mol. Sci. 2022, 23, 2171. [Google Scholar] [CrossRef]
  25. Asher, D.R.; Cerny, A.M.; Finberg, R.W. The erythrocyte viral trap: Transgenic expression of viral receptor on erythrocytes attenuates coxsackievirus B infection. Proc. Natl. Acad. Sci. USA 2005, 102, 12897–12902. [Google Scholar] [CrossRef]
  26. Hoffmann, M.A.G.; Kieffer, C.; Bjorkman, P.J. In vitro characterization of engineered red blood cells as viral traps against HIV-1 and SARS-CoV-2. Mol. Ther. Methods Clin. Dev. 2021, 21, 161–170. [Google Scholar] [CrossRef] [PubMed]
  27. Thomas, T.; Stefanoni, D.; Dzieciatkowska, M.; Issaian, A.; Nemkov, T.; Hill, R.C.; Francis, R.O.; Hudson, K.E.; Buehler, P.W.; Zimring, J.C.; et al. Evidence of Structural Protein Damage and Membrane Lipid Remodeling in Red Blood Cells from COVID-19 Patients. J. Proteome Res. 2020, 19, 4455–4469. [Google Scholar] [CrossRef] [PubMed]
  28. D’Alessandro, A.; Krisnevskaya, E.; Leguizamon, V.; Hernández, I.; de la Torre, C.; Bech, J.-J.; Navarro, J.-T.; Vives-Corrons, J.-L. SARS-CoV-2 Infection and Anemia—A Focus on RBC Deformability and Membrane Proteomics—Integrated Observational Prospective Study. Microorganisms 2024, 12, 453. [Google Scholar] [CrossRef] [PubMed]
  29. Kronstein-Wiedemann, R.; Stadtmüller, M.; Traikov, S.; Georgi, M.; Teichert, M.; Yosef, H.; Wallenborn, J.; Karl, A.; Schütze, K.; Wagner, M.; et al. SARS-CoV-2 Infects Red Blood Cell Progenitors and Dysregulates Hemoglobin and Iron Metabolism. Stem Cell Rev. Rep. 2022, 18, 1809–1821. [Google Scholar] [CrossRef]
  30. Lechuga, G.C.; Souza-Silva, F.; Sacramento, C.Q.; Trugilho, M.R.O.; Valente, R.H.; Napoleão-Pêgo, P.; Dias, S.S.G.; Fintelman-Rodrigues, N.; Temerozo, J.R.; Carels, N.; et al. SARS-CoV-2 Proteins Bind to Hemoglobin and Its Metabolites. Int. J. Mol. Sci. 2021, 22, 9035. [Google Scholar] [CrossRef]
  31. Bouchla, A.; Kriebardis, A.G.; Georgatzakou, H.T.; Fortis, S.P.; Thomopoulos, T.P.; Lekkakou, L.; Markakis, K.; Gkotzias, D.; Panagiotou, A.; Papageorgiou, E.G.; et al. Red Blood Cell Abnormalities as the Mirror of SARS-CoV-2 Disease Severity: A Pilot Study. Front. Physiol. 2021, 12, 825055. [Google Scholar] [CrossRef]
  32. Grau, M.; Ibershoff, L.; Zacher, J.; Bros, J.; Tomschi, F.; Diebold, K.F.; Predel, H.G.; Bloch, W. Even patients with mild COVID-19 symptoms after SARS-CoV-2 infection show prolonged altered red blood cell morphology and rheological parameters. J. Cell Mol. Med. 2022, 26, 3022–3030. [Google Scholar] [CrossRef]
  33. Klei, T.R.; Meinderts, S.M.; van den Berg, T.K.; van Bruggen, R. From the Cradle to the Grave: The Role of Macrophages in Erythropoiesis and Erythrophagocytosis. Front. Immunol. 2017, 8, 73. [Google Scholar] [CrossRef] [PubMed]
  34. Borges, M.D.; Sesti-Costa, R. Macrophages: Key players in erythrocyte turnover. Hematol. Transfus. Cell Ther. 2022, 44, 574–581. [Google Scholar] [CrossRef] [PubMed]
  35. Yu, S.; Ge, H.; Li, S.; Qiu, H.-J. Modulation of Macrophage Polarization by Viruses: Turning Off/On Host Antiviral Responses. Front. Microbiol. 2022, 13, 839585. [Google Scholar] [CrossRef]
  36. Shi, F.; Xu, Z.; Gao, P.; Qu, Y.; Ge, X.; Zhang, Y.; Han, J.; Guo, X.; Zhou, L.; Yang, H. African swine fever virus infection enhances CD14-dependent phagocytosis of porcine alveolar macrophages to promote bacterial uptake and apoptotic body-mediated viral transmission. J. Virol. 2025, 99, e0069025. [Google Scholar] [CrossRef] [PubMed]
  37. Wang, H.; Li, Z.; Niu, J.; Xu, Y.; Ma, L.; Lu, A.; Wang, X.; Qian, Z.; Huang, Z.; Jin, X.; et al. Antiviral effects of ferric ammonium citrate. Cell Discov. 2018, 4, 14. [Google Scholar] [CrossRef]
  38. Liao, Z.; Wang, C.; Tang, X.; Yang, M.; Duan, Z.; Liu, L.; Lu, S.; Ma, L.; Cheng, R.; Wang, G.; et al. Human transferrin receptor can mediate SARS-CoV-2 infection. Proc. Natl. Acad. Sci. USA 2024, 121, e2317026121. [Google Scholar] [CrossRef]
  39. Mazel-Sanchez, B.; Niu, C.; Williams, N.; Bachmann, M.; Choltus, H.; Silva, F.; Serre-Beinier, V.; Karenovics, W.; Iwaszkiewicz, J.; Zoete, V.; et al. Influenza A virus exploits transferrin receptor recycling to enter host cells. Proc. Natl. Acad. Sci. USA 2023, 120, e2214936120. [Google Scholar] [CrossRef]
  40. Zhang, S.; Cao, Y.; Yang, Q. Transferrin receptor 1 levels at the cell surface influence the susceptibility of newborn piglets to PEDV infection. PLoS Pathog. 2020, 16, e1008682. [Google Scholar] [CrossRef]
  41. Zhu, Y.; Tong, L.; Nie, K.; Wiwatanaratanabutr, I.; Sun, P.; Li, Q.; Yu, X.; Wu, P.; Wu, T.; Yu, C.; et al. Host serum iron modulates dengue virus acquisition by mosquitoes. Nat. Microbiol. 2019, 4, 2405–2415. [Google Scholar] [CrossRef]
  42. Esan, M.O.; van Hensbroek, M.B.; Nkhoma, E.; Musicha, C.; White, S.A.; Ter Kuile, F.O.; Phiri, K.S. Iron supplementation in HIV-infected Malawian children with anemia: A double-blind, randomized, controlled trial. Clin. Infect. Dis. 2013, 57, 1626–1634. [Google Scholar] [CrossRef] [PubMed]
Vetsci 13 00042 g001
Figure 1. Detection of TGEV in the lung and small intestine. Viral loads in collected samples were quantified by RT-qPCR. Different letters indicate significant difference (p < 0.05), whereas identical letters indicate no significant difference (p > 0.05).
Figure 1. Detection of TGEV in the lung and small intestine. Viral loads in collected samples were quantified by RT-qPCR. Different letters indicate significant difference (p < 0.05), whereas identical letters indicate no significant difference (p > 0.05).
Vetsci 13 00042 g001
Vetsci 13 00042 g002
Figure 2. Detection of TGEV in RBCs from infected piglets. (A) Viral RNA levels in RBCs were quantified by RT-qPCR. (B) Infectious viral titers in RBCs were determined by the plaque assay. (C) TGEV-positive RBCs were identified by flow cytometry. (D) Quantification of TGEV-positive cells. Different letters indicate significant difference (p < 0.05), whereas identical letters indicate no significant difference (p > 0.05).
Figure 2. Detection of TGEV in RBCs from infected piglets. (A) Viral RNA levels in RBCs were quantified by RT-qPCR. (B) Infectious viral titers in RBCs were determined by the plaque assay. (C) TGEV-positive RBCs were identified by flow cytometry. (D) Quantification of TGEV-positive cells. Different letters indicate significant difference (p < 0.05), whereas identical letters indicate no significant difference (p > 0.05).
Vetsci 13 00042 g002
Vetsci 13 00042 g003
Figure 3. TGEV binding to RBCs. (A) TGEV RNA copies were quantified by RT-qPCR. (B) Viral titer in RBCs was determined by the plaque assay. (C) Quantification of viral titer. (D) Percentages of TGEV-positive RBCs were detected by flow cytometry. (E) Quantification of TGEV-positive RBCs. Different letters indicate significant differences (p < 0.05), whereas identical letters indicate no significant difference (p > 0.05).
Figure 3. TGEV binding to RBCs. (A) TGEV RNA copies were quantified by RT-qPCR. (B) Viral titer in RBCs was determined by the plaque assay. (C) Quantification of viral titer. (D) Percentages of TGEV-positive RBCs were detected by flow cytometry. (E) Quantification of TGEV-positive RBCs. Different letters indicate significant differences (p < 0.05), whereas identical letters indicate no significant difference (p > 0.05).
Vetsci 13 00042 g003
Vetsci 13 00042 g004
Figure 4. Role of SA in TGEV binding to RBCs. RBCs were pretreated with 0.1 U/mL NA at 37 °C for 1 h and subsequently inoculated with TGEV at 4 °C or 37 °C for 1 h. Viral RNA levels, infectious titers, and percentages of TGEV-positive RBCs were measured by RT-qPCR (A), the plaque assay (B,C), and flow cytometry (D,E), respectively. Different letters indicate significant differences (p < 0.05), whereas identical letters indicate no significant difference (p > 0.05).
Figure 4. Role of SA in TGEV binding to RBCs. RBCs were pretreated with 0.1 U/mL NA at 37 °C for 1 h and subsequently inoculated with TGEV at 4 °C or 37 °C for 1 h. Viral RNA levels, infectious titers, and percentages of TGEV-positive RBCs were measured by RT-qPCR (A), the plaque assay (B,C), and flow cytometry (D,E), respectively. Different letters indicate significant differences (p < 0.05), whereas identical letters indicate no significant difference (p > 0.05).
Vetsci 13 00042 g004
Vetsci 13 00042 g005
Figure 5. Morphology abnormalities of TGEV-infected RBCs. RBCs were inoculated with TGEV and analyzed by multiple approaches. (A) Diff-Quik staining images were obtained at ×40 magnification. Scale bars = 5 μm. (B) FSC and SSC parameters of RBCs were analyzed by flow cytometry. (C) SEM image showing ultrastructural changs in RBC. Scale bars = 1 μm.
Figure 5. Morphology abnormalities of TGEV-infected RBCs. RBCs were inoculated with TGEV and analyzed by multiple approaches. (A) Diff-Quik staining images were obtained at ×40 magnification. Scale bars = 5 μm. (B) FSC and SSC parameters of RBCs were analyzed by flow cytometry. (C) SEM image showing ultrastructural changs in RBC. Scale bars = 1 μm.
Vetsci 13 00042 g005
Vetsci 13 00042 g006
Figure 6. Effects of TGEV adhesion on RBC membrane integrity. (A) Osmotic fragility of RBCs infected with TGEV (MOI = 1) were detected at 3, 6, 12, and 24 hpi. (B) Osmotic fragility of RBCs was measured after incubation with TGEV at different MOIs for 1 h. (C) PS exposure on RBCs was detected by flow cytometry. (D) Quantification of PS-positive RBCs. Different letters indicate significant differences (p < 0.05); the same letter indicates no significant difference (p > 0.05).
Figure 6. Effects of TGEV adhesion on RBC membrane integrity. (A) Osmotic fragility of RBCs infected with TGEV (MOI = 1) were detected at 3, 6, 12, and 24 hpi. (B) Osmotic fragility of RBCs was measured after incubation with TGEV at different MOIs for 1 h. (C) PS exposure on RBCs was detected by flow cytometry. (D) Quantification of PS-positive RBCs. Different letters indicate significant differences (p < 0.05); the same letter indicates no significant difference (p > 0.05).
Vetsci 13 00042 g006
Vetsci 13 00042 g007
Figure 7. Effects of TGEV infection on hemoglobin in RBCs. (A) Average Raman spectra of RBCs. (B) Histogram of the most significant Raman peaks. (C,D) Levels of oxyhemoglobin (C) and methemoglobin (D) in TGEV-bound RBCs measured at 3, 6, 12, and 24 hpi. Different letters indicate significant differences (p < 0.05); the same letter indicates no significant difference (p > 0.05).
Figure 7. Effects of TGEV infection on hemoglobin in RBCs. (A) Average Raman spectra of RBCs. (B) Histogram of the most significant Raman peaks. (C,D) Levels of oxyhemoglobin (C) and methemoglobin (D) in TGEV-bound RBCs measured at 3, 6, 12, and 24 hpi. Different letters indicate significant differences (p < 0.05); the same letter indicates no significant difference (p > 0.05).
Vetsci 13 00042 g007
Vetsci 13 00042 g008
Figure 8. Effects of TGEV infection on macrophage phagocytosis. (A) SSC values of macrophages were analyzed by flow cytometry. (B) Fluorescence intensity of macrophages engulfing RBCs was measured by flow cytometry. (C) Quantification of fluorescence intensity. Different letters indicate significant differences (p < 0.05); the same letter indicates no significant difference (p > 0.05).
Figure 8. Effects of TGEV infection on macrophage phagocytosis. (A) SSC values of macrophages were analyzed by flow cytometry. (B) Fluorescence intensity of macrophages engulfing RBCs was measured by flow cytometry. (C) Quantification of fluorescence intensity. Different letters indicate significant differences (p < 0.05); the same letter indicates no significant difference (p > 0.05).
Vetsci 13 00042 g008
Vetsci 13 00042 g009
Figure 9. Iron affects TGEV infection. (A) Microscopic observations of liver and spleen sections stained with Prussian blue. Scale bars = 20 or 100 μm. (B) Serun iron in TGEV-infected and healthy piglets. (C) ST cells were pretreated with DFOM (100 μM) or FAC (100 nM) for 6 h to detect the expression of TFR1. (D,E) ST cells were pretreated with DFOM or FAC and then infected with TGEV (MOI = 1). Viral RNA or viral protein was analyzed by RT-qPCR (D) or WB (E) at 24 hpi. Different letters indicate significant differences (p < 0.05); the same letter indicates no significant difference (p > 0.05).
Figure 9. Iron affects TGEV infection. (A) Microscopic observations of liver and spleen sections stained with Prussian blue. Scale bars = 20 or 100 μm. (B) Serun iron in TGEV-infected and healthy piglets. (C) ST cells were pretreated with DFOM (100 μM) or FAC (100 nM) for 6 h to detect the expression of TFR1. (D,E) ST cells were pretreated with DFOM or FAC and then infected with TGEV (MOI = 1). Viral RNA or viral protein was analyzed by RT-qPCR (D) or WB (E) at 24 hpi. Different letters indicate significant differences (p < 0.05); the same letter indicates no significant difference (p > 0.05).
Vetsci 13 00042 g009
Table 1. Raman spectrum peak position and material identification.
Table 1. Raman spectrum peak position and material identification.
Peak Position (cm−1)Assignment
1225protein
1248Amide III/heme aggregation
1355Fe2+/deoxyHb
1375Fe3+/oxyHb
1565tryptophan
1585cytochrome c
1639hemoglobin
1650Amide I
Table 2. Blood parameters of the piglets.
Table 2. Blood parameters of the piglets.
Blood ParametersUnitControlTGEV
RBC1012/L6.477 ± 3.0594.277 ± 1.767
HGBg/L116.3 ± 51.8778.33 ± 32.72
HCT%38.43 ± 17.2524.27 ± 9.765
MCVfL59.97 ± 1.23457.13 ± 5.297
MCHpg18.1 ± 0.435918.37 ± 2.996
MCHCg/L302.3 ± 3.215321 ± 21.63
RDW_CV%27.7 ± 3.503 a19.73 ± 1.358 b
RDW_SDfL50.57 ± 2.829 a38.13 ± 2.779 b
PLT109/L889 ± 426.9596 ± 369.9
MPVfL12.17 ± 3.75310 ± 0.7
PDW%14.93 ± 0.503314.63 ± 0.6658
PCT%0.2473 ± 0.14260.1603 ± 0.007506
pH 7.265 ± 0.15267.237 ± 0.1617
O2mmHg51.33 ± 8.62250.67 ± 4.041
CO2mmHg35.33 ± 2.887 a42.33 ± 2.887 b
Note: HGB: hemoglobin; HCT: hematocrit; MCV: mean corpuscular volume; MCH: mean corpuscular hemoglobin; MCHC: mean corpuscular hemoglobin concentration; RDW_CV: red blood cell distribution width–coefficient of variation; RDW_SD: red cell distribution width–standard deviation; PLT: platelet count; MPV: mean platelet volume; PDW: platelet distribution width; PCT: plateletcrit. Different letters indicate significant difference (p < 0.05), whereas identical letters indicate no significant difference (p > 0.05).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Xia, L.; Wang, Z.; He, Y.; Wang, J.; Ren, J.; Zhang, E.; Liu, Z.; Li, Y.; Li, Z.; Wei, Z. Transmissible Gastroenteritis Virus Binding to Red Blood Cells Disrupts Iron Homeostasis and Promotes Viral Infection. Vet. Sci. 2026, 13, 42. https://doi.org/10.3390/vetsci13010042

AMA Style

Xia L, Wang Z, He Y, Wang J, Ren J, Zhang E, Liu Z, Li Y, Li Z, Wei Z. Transmissible Gastroenteritis Virus Binding to Red Blood Cells Disrupts Iron Homeostasis and Promotes Viral Infection. Veterinary Sciences. 2026; 13(1):42. https://doi.org/10.3390/vetsci13010042

Chicago/Turabian Style

Xia, Lu, Ziqi Wang, Yeqing He, Jingwen Wang, Junyuan Ren, Erhao Zhang, Zhonghu Liu, Yilei Li, Zi Li, and Zhanyong Wei. 2026. "Transmissible Gastroenteritis Virus Binding to Red Blood Cells Disrupts Iron Homeostasis and Promotes Viral Infection" Veterinary Sciences 13, no. 1: 42. https://doi.org/10.3390/vetsci13010042

APA Style

Xia, L., Wang, Z., He, Y., Wang, J., Ren, J., Zhang, E., Liu, Z., Li, Y., Li, Z., & Wei, Z. (2026). Transmissible Gastroenteritis Virus Binding to Red Blood Cells Disrupts Iron Homeostasis and Promotes Viral Infection. Veterinary Sciences, 13(1), 42. https://doi.org/10.3390/vetsci13010042

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop